Circulating Retinol-Binding Protein 4 and Subclinical Cardiovascular Disease in Elderly

  1. Erik Ingelsson, MD, PhD (erik.ingelsson{at}ki.se)1 and
  2. Lars Lind, MD, PhD2
  1. 1) Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
  2. 2) Department of Medical Sciences, Uppsala University, Uppsala, Sweden

    Abstract

    Objective: We evaluated associations of serum retinol-binding protein 4 (RBP4) to subclinical cardiovascular disease (CVD).

    Research Design and Methods: Subclinical CVD was measured with echocardiography, carotid artery ultrasound, brachial artery ultrasound and invasive forearm endothelial vasoreactivity in 1008 70-year old participants (50% women) of the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study.

    Results: In analyses adjusted for multiple CVD risk factors, we observed inverse associations of RBP4 with carotid artery intima-media (β, −0.39; 95% confidence interval, −0.55, −0.22) and plaque (β, −0.33; 95% confidence interval, −0.60, −0.05) echogenicity (gray scale median).

    Conclusions: Circulating RBP4 concentrations were inversely associated with intima-media and plaque echogenicity in carotid arteries. These findings imply that RBP4 could be involved in the development of atherosclerosis.

    Footnotes

      • Received September 8, 2008.
      • Accepted December 17, 2008.